Antaria

What Antaria does

Antaria Pharma is a Luxembourg-domiciled (Antaria Luxembourg S.A., registered capital €440,000) specialty finance company founded in 2019 that provides alternative debt financing exclusively to pharmacists operating in France. The company was created from the partnership of a pharmacist and a banker to address a structural gap in French pharmacy financing, where traditional banks have tightened credit conditions and demand personal contributions and medical insurance that exclude many practitioners from ownership.

Its core product, the "Financement Libérateur" (Intelligent Financing), uses a "prêt in-fine" (interest-only) structure where borrowers pay only monthly interest tied to Euribor, with principal repayable at maturity over 6–12 year terms. This is wrapped around five lifecycle modules—Se Lancer (first installation), Grandir (expansion), Rebondir (no-insurance bounce-back), Se Libérer (cash-out liquidity in ~4 weeks), and Transmettre (succession)—plus an emerging Solution Zéro Apport™ for zero personal contribution. Crucially, Antaria holds no equity; its value derives from operating within French regulations that prohibit non-pharmacist capital ownership, making pure debt the only permissible structure for external financiers.

Revenue derives from interest income on the loan book, one-time structuring and file fees, and professional services (audit, feasibility, legal preparation, contract review, ongoing reporting). Distribution combines a website-based online simulator, an inside-sales phone team, ESSEC Business School training partnerships as a top-of-funnel channel for young pharmacists, and earned media across pharmacy press and BFM Business. The company has accompanied 100+ pharmacists since inception and operates with a 1–10 employee headcount from a Paris bureau while remaining legally headquartered in Luxembourg.

Name

Antaria

Legal name

Antaria Luxembourg S.A.

Website

https://antaria-pharma.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Antaria Pharma is a Luxembourg-domiciled specialty financier providing alternative debt (prêt in-fine) solutions to French pharmacists across career stages, including installation, expansion, cash-out, and succession, with no equity ownership.

Ownership category

akta.pro rank

Headquarters

HQ city

Luxembourg

HQ country

Luxembourg

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Capital deployed (loan principal funded under the in-fine model), Personnel (transaction experts, lawyers, accountants, sales staff), Operations (compliance, structuring, file processing), Marketing or Sales (PR, content, partnership training programs), Technology or R&D (simulator platform, CRM, website), Infrastructure (Luxembourg HQ and Paris office)

Revenue model

1. Financing interest income: Antaria Pharma structures debt financing for pharmacists with interest rates tied to monthly Euribor. The company earns interest income on the loans structured. Financing terms range from 6 to 12 years with monthly interest payments.
2. Structuring fees: Initial file processing fees and structuring fees associated with financing arrangements. The company charges all-inclusive financing rate and pre-negotiated bank account fees as part of the financing package.
3. Professional services: Advisory and accompaniment services including transaction consulting, financial management advice, and ongoing support. Services include audit of target pharmacy, feasibility analysis, legal framework preparation, contract review, and monthly performance reporting.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

Core offering

Antaria provides alternative debt-financing solutions tailored to French pharmacists across all career stages, using an "in-fine" prêt structure where borrowers pay monthly interest only and repay principal at maturity. The offering combines the Financement Libérateur product family (Se Lancer, Grandir, Rebondir, Se Libérer, Transmettre) with a Solution Zéro Apport™ zero-contribution option and an end-to-end Accompagnement sur-mesure advisory service covering pharmacy audit, transaction execution, and ongoing financial management.

Product overview

Antaria Pharma is a financial and strategic partner for pharmacists offering a unified financing ecosystem centered on its 'Financement Libérateur' (Intelligent Financing) product. The portfolio includes five distinct product modules addressing different career stages: 'Se Lancer' for young graduates, 'Grandir' for career acceleration, 'Rebondir' for those without loan insurance, 'Se Libérer' (Cash-out) for liquidity access, and 'Transmettre' for succession planning. An emerging 'Solution Zéro Apport™' aims to eliminate the personal contribution requirement. All products leverage a 'prêt in-fine' model preserving 100% capital ownership. Complementary services include tailored expert support (Accompagnement sur-mesure), an online investment simulator, and an ESSEC partnership for business education. The company does not take equity stakes in pharmacies.

Differentiator

Problem solved

Functional benefit

Products and services

• Financement Libérateur (Intelligent Financing) Core debt-financing product leveraging credit market access to structure prêt in-fine loans for French pharmacists, requiring monthly interest-only payments with flexible principal repayment at maturity over 6–12 year terms. The pharmacist retains 100% ownership of the pharmacy.
• Se Lancer (Career Launch for Young Graduates) Financing solution for newly graduated pharmacists to become owners of their first pharmacy, requiring approximately 10% personal contribution and providing access to experienced pharmacist partners.
• Grandir (Growth & Expansion) Career-acceleration financing for established pharmacists seeking to move toward larger pharmacy structures or co-invest with fellow pharmacists.
• Rebondir (Bounce Back for Uninsured Pharmacists) Financing for pharmacists refused by banks due to health issues; explicitly does not require medical insurance as a condition for obtaining credit.
• Se Libérer (Cash-Out Liquidity) Liquidity solution allowing pharmacists to access capital tied up in their pharmacy without selling it; funds delivered in approximately 4 weeks for purposes such as buying out partners or co-investing in new projects.
• Transmettre (Pharmacy Succession Transmission) Succession solution that pre-arranges buyer financing before a pharmacy sale, simplifying transmission and ensuring transaction completion for retiring pharmacists.
• Solution Zéro Apport™ (Zero-Contribution Financing) Zero-contribution financing variant exclusive to Antaria, designed so that absence of personal assets is no longer a blocking factor for young pharmacists acquiring a first pharmacy.
• Accompagnement sur-mesure (Tailored Expert Support) End-to-end expert accompaniment from project audit and feasibility analysis through legal framework preparation, contract review, transaction execution, and post-financing management support; delivered by lawyers, accountants, and transaction specialists.

Quantifiable outcome

• Monthly payments reduced by more than 50%
• +5 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• ESSEC Business SchoolcoreStrategic or Co-development Partner · 1 May 2026Antaria Pharma has partnered with ESSEC Business School to offer a free 9-day training program in Management and Finance for pharmacy students and young pharmacists. The program, valued at €7,000, is delivered at ESSEC CNIT La Défense location. Reserved for 6th-year pharmacy students and pharmacists with less than 10 years of experience. Includes certificate from ESSEC Executive Education and access to Antaria expert network. This partnership positions Antaria as the strategic partner for young pharmacists' career development.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Market position

Strengths1 record

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

• LinkedInfr.linkedin.com/company/antaria-pharma
• Instagraminstagram.com/antaria_pharma

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Antaria